Cryopreservation
Cryopreservation
Cryopreservation is a process that involves cooling biological systems to temperatures as low as -196 oC to stop their metabolic processes, which achieves long-term storage. Cryopreservation is essential for the maintenance of off-the-shelf whole organisms (e.g., embryos) for maintaining biodiversity and food sustainability, and cells, tissues, and organoids used in healthcare (life-saving therapies and research and clinical testbeds). Vitrification (a stable and amorphous versus crystalline state) has shown success in all of these biosystems, but it requires a careful combination of the lowest possible cryoprotectant (CPA) concentrations (to avoid toxicity) and the highest possible cooling rates (to avoid ice formation). The traditional vitrification methods (e.g., droplet-based vitrification) suffer from the trade-off between sample geometry/scale and achievable warming rates. Specifically, to achieve high cooling and warming rates, the sample size needs to remain incredibly small, limiting the throughput and translation.
I explored the fastest possible cooling and rewarming rates by advancing a scalable cryomesh-based platform technology to improve vitrification in numerous µm to mm scale biological systems with a particular focus on the following application areas:
1). Establishing conditions to achieve the conduction-dominated cryopreservation platform (from a heat transfer perspective).
2). Cryopreservation of coral larvae.
3). Cryopreservation of Drosophila embryo.
4). Pancreatic islets cryopreservation.
5). Desings for biobanking.
Conduction-dominated cryopreservation platform
The process of cryopreservation involves heat transfer during cooling and rewarming, which plays a crucial role in determining the success of vitrification and viability. The improved cooling rate is enhanced mainly by i) high thermal conductivity mesh material (k ≥ 10 W/m/K) to achieve conduction-dominated behavior and ii) vertical plunging method to reduce the Leidenfrost effect achieving higher convective heat transfer rates, which enhances the heat release of the biosystem into LN2 (liquid nitrogen). This cryomesh enables the preservation of large-quantity biosystems with high throughput, consistency easy protocol, and high viability, which has the potential to be a standard tool for cryopreservation research due to its easy scalability with surface area.
Coral larvae cryopreservation
Climate change has dramatically impacted oceanic ecosystems and endangered many of the coral populations around the globe. One of the most effective methods to secure the biodiversity of coral is the cryopreservation of coral larvae to assist gene flow and rewild reefs. The conduction-dominated cryomesh approach for coral larvae cryopreservation with a high survival rate (85%) and scalability to larger numbers (> 200 per loading) using larger or multiple cryomesh. Compared to the previous approach of laser rewarming, the cryomesh method doubled the survival rate and only needed 0.2% of the operation time compared with laser rewarming. The cryomesh has been used for the biobanking of mushroom coral larvae in Hawaii by our collaborators from the Smithsonian Institute and the University of Hawaii, as well as by collaborators from Taronga Conservation Society Australia and the University of New South Wales in Australia for biobanking mushroom coral from Great Barrier Reef.
Drosophila embryo cryopreservation
The fruit fly (Drosophila melanogaster) is a foundational genetic model organism for biological research, which has >160,000 unique genotypes held in individual research laboratories and stock centers worldwide with a growing number. Cryopreservation has the potential to decrease stock maintenance costs and reduce the risk of stock loss for long-term storage. I demonstrated that the conduction-dominated cryomesh approach can lower the required CPA concentration for Drosophila embryos while achieving high hatch rates (3.3 X higher than conventional cryomesh). This will be critical for expanding use to biosystems that are more susceptible to CPA toxicity. This work also collaborates with Bloomington Drosophila Stock Center (BDSC), working to develop a cryopreservation package for other stock centers and Drosophila labs, increasing the dissemination and impact of this work.
Pancreatic islets cryopreservation
Pancreatic islet transplantation has the potential to facilitate a cure for diabetes, a debilitating disease that affects >34M people in the U.S. alone, and causes >83,000 deaths. However, a major barrier to islet transplantation is a lack of sufficient quantities of high-quality islets when and where they are needed. A successful islet transplantation typically requires on the order of 1 million islets, while a donor pancreas only yields 200,000 to 500,000 islets. This leads to a practical barrier that has limited the advancement of this life-saving approach. To address this, I redesigned the conduction-dominated cryomesh for cryopreservation of clinical islet quantities (>1 million islets) with high throughput at high viability > 85%. This project involves a close collaboration with the UMN Department of Surgery and the Mayo Clinic. We are now working on adapting these methods for clinical use and establishing appropriate partnerships to move this into the clinic.
Publications:
Z. Guo, N. Zuchowicz, J. Bouwmeester, A. S. Joshi, A. Neisch, K. Smith, J. Daly, M. L. Etheridge, E. B. Finger, S. B. Kodandaramaiah, T. Hays, M. Hagedorn, J. C. Bischof, "Conduction-Dominated Cryomesh for Organism Vitrification", Advanced Science,11(3), 2303317 (2024).
Fundings
Current Awarded:
1. 2023 ATP-Bio Stakeholder-Inspired Research Program (SIRP), Role: Co-PI
Title: Fabrication of next-generation cryomesh for organism vitrification
Amount: $50,000
2. 2023 ATP-Bio Stakeholder-Inspired Research Program (SIRP), Role: Participant
Title: All-in-one system (container technologies) for cryogenic transfer, transport, and storage of clinical scale (human organs) vitrified samples
Amount: $50,000
3. 2023 ATP-Bio Convergent Research Program (RFP001), Role: Participant
Title: Cryopreservation of 3D-engineered micro-physiological heart tissue (EMHT)
Amount: $50,000